The approval is a win for Merck, which is working to diversify its revenue stream as its blockbuster cancer drug Keytruda nears a loss of market exclusivity.
Source: https://www.cnbc.com/2024/03/26/fda-app ... ition.html
FDA approves Merck's drug for rare, deadly lung condition
